p19ARF links the tumour suppressor p53 to Ras (original) (raw)

• Scientific Correspondence
• Published: 10 September 1998

Nature volume 395, pages 125–126 (1998)Cite this article

• 1816 Accesses
• 564 Citations
• 3 Altmetric
• Metrics details

Abstract

Normal healthy cells possess safeguard mechanisms that sense oncogenic signals and trigger anti-tumorigenic responses that limit the proliferative potential of cells harbouring active oncogenes1. In particular, expression of the Ras oncogene in normal primary cells causes a cell-cycle arrest that involves the activation of the tumoursuppressor protein p53 (ref. 2). It has recently been reported that the tumour-suppressor p19ARF can activate p53 (3–5). Here we show that p19ARF in the mouse (the human homologue is called p14ARF) is essential for the activation of p53 in response to oncogenic Ras. These results, together with the finding that p19ARF does not mediate the activation of p53 by DNA damage6, dissociate the activation of p53 into two pathways: one pathway is induced by DNA damage and is independent of p19ARF, whereas the other pathway is induced by oncogenic Ras and is dependent on p19ARF.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

References

1. Weinberg, R. A. Cell 88, 573–575 (1997).
   Google Scholar
2. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Cell 88, 593–602 (1997).
   Google Scholar
3. Pomerantz, J.et al. Cell 92, 713–723 (1998).
   Google Scholar
4. Zhang, Y., Xiong, Y. & Yarbrough, W. G. Cell 92, 725–734 (1998).
   Google Scholar
5. Kamijo, T.et al. Proc. Natl Acad. Sci. USA 95, 8292–8297 (1998).
   Google Scholar
6. Kamijo, T.et al. Cell 91, 649–659 (1997).
   Google Scholar
7. Levine, A. J. Cell 88, 323–331 (1997).
   Google Scholar
8. Haber, D. A. Cell 91, 555–558 (1997).
   Google Scholar
9. Serrano, M.et al. Cell 85, 27–37 (1996).
   Google Scholar
10. Quelle, D. E., Cheng, M., Ashmun, R. A. & Sherr, C. J. Proc. Natl Acad. Sci. USA 94, 669–673 (1997).
    Google Scholar
11. Zindy, F.et al. Genes Dev. 12, 2424–2433 (1998).
    Google Scholar
12. de Stanchina, E.et al. Genes Dev. 12, 2434–2442 (1998).
    Google Scholar

Download references

Author information

Authors and Affiliations

1. Department of Immunology and Oncology, Centro Nacional de Biotecnologa, CSIC, Campus de Cantoblanco, Madrid, E-28049, Spain
   Ignacio Palmero, Cristina Pantoja & Manuel Serrano

Authors

1. Ignacio Palmero
2. Cristina Pantoja
3. Manuel Serrano

Rights and permissions

About this article

Cite this article

Palmero, I., Pantoja, C. & Serrano, M. p19ARF links the tumour suppressor p53 to Ras.Nature 395, 125–126 (1998). https://doi.org/10.1038/25870

Download citation

• Issue date: 10 September 1998
• DOI: https://doi.org/10.1038/25870

This article is cited by